Notice: This company has been marked as potentially delisted and may not be actively trading. Aevi Genomic Medicine (GNMX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Plc Astrazeneca's Net WorthFebruary 9, 2024 | benzinga.comAevi Genomic Medicine, Inc.September 10, 2023 | thestreet.comForecast 2023-2027, Genomic Medicine Market: An Analysing Business Strategies and TrendsMarch 11, 2023 | marketwatch.comSucheta Bhatt, MD, FACMG and Rong Mao, MD, FACMG Elected to Board of Directors of the ACMG Foundation for Genetic and Genomic MedicineMarch 7, 2023 | finance.yahoo.comThe Rise of Genomic Medicine Market Research 2023-2027: Opportunities and Challenges with Top Countries DataFebruary 24, 2023 | marketwatch.comNutritional Genomics Company, GenoPalate, Launches Personalized Supplement Line, GenoVitJanuary 30, 2023 | finance.yahoo.comGenomic Vision Strengthens Leadership Team With the Appointment of Frederic Hammel as Chief Operating OfficerJanuary 26, 2023 | finanznachrichten.deDante Genomics Unveils Digital Health Population Genomic Programs at the United Nations General Assembly Science SummitOctober 7, 2022 | finance.yahoo.com Get Aevi Genomic Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for GNMX and its competitors with MarketBeat's FREE daily newsletter. Email Address GNMX Media Mentions By Week GNMX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNMX News Sentiment▼0.000.45▲Average Medical News Sentiment GNMX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNMX Articles This Week▼00▲GNMX Articles Average Week Get Aevi Genomic Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for GNMX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALVR News Today ATRA News Today ACHL News Today DYAI News Today ELEV News Today OKYO News Today DTIL News Today SRZN News Today PASG News Today INKT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNMX) was last updated on 2/7/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aevi Genomic Medicine, LLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Aevi Genomic Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
